Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes -: Follow-up of the Seattle Family Study

被引:62
作者
Greenbaum, CJ
Sears, KL
Kahn, SE
Palmer, JP
机构
[1] DVA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.2337/diabetes.48.1.170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 8.5 islet cell antibody (ICA)(+) or insulin autoantibody (IAA)(+) relatives of patients with type I diabetes have been followed as part of the Seattle family Study for a mean of 2.8 fears. Of the subjects followed, 10 developed diabetes during this time period, The presence of GAD antibodies was strongly associated with the development of diabetes. Tn contrast, the presence of IAAs did not influence the risk of diabetes among ICA(+) GAD(+) subjects. When either the initial absolute acute insulin response to glucose (AIR(g)) or the AIR(g) percentile, which accounts for the individual's insulin sensitivity, was below the 10th percentile of normal subjects, the risk of diabetes approached 50% at 5 years. However, impaired beta-cell function did not influence the risk of diabetes among those who were GAD(+). There were 13 subjects with low AIR(g) and 13 subjects with two or more antibodies who had not progressed to diabetes during the course of the study, Other measurements of beta-cell function or demographic characteristics were not different in this grout of nonprogressors compared with those with low AIR, who did not progress to diabetes. We! conclude that ICA+ relatives with GAD antibodies or low AIR, have a high risk for development of diabetes but among ICA(+) GAD(+) relatives, the addition of IAA or a single determination of AIR, does not enhance the prediction of diabetes, We suggest that prediction of diabetes risk depends on both the type and the number of antibodies present. In addition, there are a group of ICA(+) relatives with low AIR, and/or multiple antibodies who have not progressed to diabetes over the course of the study.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 26 条
  • [11] GREENBAUM CJ, 1996, DIABETES PREDICTION, P63
  • [12] HEATON DA, 1989, DIABETOLOGIA, V32, P814
  • [13] INCREASED SPECIFICITY AND SENSITIVITY OF INSULIN ANTIBODY MEASUREMENTS IN AUTOIMMUNE THYROID-DISEASE AND TYPE-I DIABETES
    HEGEWALD, MJ
    SCHOENFELD, SL
    MCCULLOCH, DK
    GREENBAUM, CJ
    KLAFF, LJ
    PALMER, JP
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 154 (01) : 61 - 68
  • [14] Islet cell antibody seroconversion in children is temporally associated with enterovirus infections
    Hiltunen, M
    Hyoty, H
    Knip, M
    Ilonen, J
    Reijonen, H
    Vahasalo, P
    Roivainen, M
    Lonnrot, M
    Leinikki, P
    Hovi, T
    Akerblom, HK
    Tuomilehto, J
    Lounamaa, R
    Toivanen, L
    Virtala, E
    Pitkaniemi, J
    Fagerlund, A
    Flittner, M
    Gustafsson, B
    Haggqvist, C
    Hakulinen, A
    Herva, L
    Hiltunen, P
    Huhtamaki, T
    Huttunen, NP
    Huupponen, T
    Hyttinen, M
    Joki, T
    Jokisalo, R
    Kaar, ML
    Kallio, S
    Kaprio, EA
    Kaski, U
    Knip, M
    Laine, L
    Lappalainen, J
    Maenpaa, J
    Makela, AL
    Niemi, K
    Niiranen, A
    Nuuja, A
    Ojajarvi, P
    Otonkoski, T
    Pihlajamaki, K
    Pontynen, S
    Rajantie, J
    Sankala, J
    Schumacher, J
    Sillanpaa, M
    Stahlberg, MR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) : 554 - 560
  • [15] A PROSPECTIVE-STUDY OF THE ROLE OF COXSACKIE-B AND OTHER ENTEROVIRUS INFECTIONS IN THE PATHOGENESIS OF IDDM
    HYOTY, H
    HILTUNEN, M
    KNIP, M
    LAAKKONEN, M
    VAHASALO, P
    KARJALAINEN, J
    KOSKELA, P
    ROIVAINEN, M
    LEINIKKI, P
    HOVI, T
    AKERBLOM, HK
    TUOMILEHTO, J
    LOUNAMAA, R
    TOIVANEN, L
    VIRTALA, E
    PITKANIEMI, J
    FAGERLUND, A
    FLITTNER, M
    GUSTAFFSON, B
    HAGGQVIST, C
    HAKULINEN, A
    HERVA, L
    HILTUNEN, P
    HUHTAMAKI, T
    HUTTUNEN, NP
    HUUPPONEN, T
    HYTTINEN, M
    JOKI, T
    JOKISALO, R
    KAAR, ML
    KALLIO, S
    KAPRIO, EA
    KASKI, U
    LAINE, L
    LAPPALAINEN, J
    MAENPAA, J
    MAKELA, AL
    NIEMI, K
    NIIRANEN, A
    NUUJA, A
    OJAJARVI, P
    OTONKOSKI, T
    PIHLAJAMAKI, K
    PONTYNEN, S
    RAJANTIE, J
    SANKALA, J
    SCHUMACHER, J
    SILLANPAA, M
    STAHLBERG, MR
    STRAHLMANN, CH
    [J]. DIABETES, 1995, 44 (06) : 652 - 657
  • [16] QUANTIFICATION OF THE RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND BETA-CELL FUNCTION IN HUMAN-SUBJECTS - EVIDENCE FOR A HYPERBOLIC FUNCTION
    KAHN, SE
    PRIGEON, RL
    MCCULLOCH, DK
    BOYKO, EJ
    BERGMAN, RN
    SCHWARTZ, MW
    NEIFING, JL
    WARD, WK
    BEARD, JC
    PALMER, JP
    PORTE, D
    [J]. DIABETES, 1993, 42 (11) : 1663 - 1672
  • [17] ISLET CELL ANTIBODIES AS PREDICTIVE MARKERS FOR IDDM IN CHILDREN WITH HIGH BACKGROUND INCIDENCE OF DISEASE
    KARJALAINEN, JK
    [J]. DIABETES, 1990, 39 (09) : 1144 - 1150
  • [18] ROLE OF GLUCOSE AND INSULIN RESISTANCE IN DEVELOPMENT OF TYPE-2 DIABETES-MELLITUS - RESULTS OF A 25-YEAR FOLLOW-UP-STUDY
    MARTIN, BC
    WARRAM, JH
    KROLEWSKI, AS
    BERGMAN, RN
    SOELDNER, JS
    KAHN, CR
    [J]. LANCET, 1992, 340 (8825) : 925 - 929
  • [19] NONPROGRESSION OF SUBCLINICAL BETA-CELL DYSFUNCTION AMONG 1ST-DEGREE RELATIVES OF IDDM PATIENTS - 5-YR FOLLOW-UP OF THE SEATTLE FAMILY STUDY
    MCCULLOCH, DK
    KLAFF, LJ
    KAHN, SE
    SCHOENFELD, SL
    GREENBAUM, CJ
    MAUSETH, RS
    BENSON, EA
    NEPOM, GT
    SHEWEY, L
    PALMER, JP
    [J]. DIABETES, 1990, 39 (05) : 549 - 556
  • [20] MEHTA V, 1996, PREDICTION PREVENTIO, P3